INTRODUCTION: The HOXB13 pGly84Glu mutation has recently been associated with an increased risk of prostate cancer but the association of other cancer sites with this allele has not been assessed. Data has suggested that HOXB13 expression levels are decreased in colorectal cancer (CRC) cell lines indicating this gene may be involved in colorectal tumourigenesis. METHODS: To evaluate a potential association of this mutation with CRC, we genotyped the mutation in 2695 CRC cases and 4593 controls from population-based registries in Canada and Australia. RESULTS: The HOXB13 pGly84Glu mutation was more common in CRC cases than controls (0.48% vs. 0.17%, P=0.02) indicating a significant association between the HOXB13 variant and CRC risk (OR=2.8; 95%CI: 1.2-6.8). This association was attenuated but remained significant with the inclusion of previously published and publicly available genotype data. Pedigree analysis of cases and controls revealed that 7/21 HOXB13 mutation carriers had a family history of prostate cancer. DISCUSSION: This report is the first to suggest a risk of CRC associated with mutations in the HOXB13 gene. These findings require further validation but may be of importance in the screening and genetic counseling of families known to carry the HOXB13 pGly84Glu mutation.
INTRODUCTION: The HOXB13pGly84Glu mutation has recently been associated with an increased risk of prostate cancer but the association of other cancer sites with this allele has not been assessed. Data has suggested that HOXB13 expression levels are decreased in colorectal cancer (CRC) cell lines indicating this gene may be involved in colorectal tumourigenesis. METHODS: To evaluate a potential association of this mutation with CRC, we genotyped the mutation in 2695 CRC cases and 4593 controls from population-based registries in Canada and Australia. RESULTS: The HOXB13pGly84Glu mutation was more common in CRC cases than controls (0.48% vs. 0.17%, P=0.02) indicating a significant association between the HOXB13 variant and CRC risk (OR=2.8; 95%CI: 1.2-6.8). This association was attenuated but remained significant with the inclusion of previously published and publicly available genotype data. Pedigree analysis of cases and controls revealed that 7/21 HOXB13 mutation carriers had a family history of prostate cancer. DISCUSSION: This report is the first to suggest a risk of CRC associated with mutations in the HOXB13 gene. These findings require further validation but may be of importance in the screening and genetic counseling of families known to carry the HOXB13pGly84Glu mutation.
Authors: Mohammad R Akbari; John Trachtenberg; Justin Lee; Stephanie Tam; Robert Bristow; Andrew Loblaw; Steven A Narod; Robert K Nam Journal: J Natl Cancer Inst Date: 2012-07-09 Impact factor: 13.506
Authors: Joan P Breyer; T Grant Avritt; Kate M McReynolds; William D Dupont; Jeffrey R Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-06-19 Impact factor: 4.254
Authors: M Cotterchio; G McKeown-Eyssen; H Sutherland; G Buchan; M Aronson; A M Easson; J Macey; E Holowaty; S Gallinger Journal: Chronic Dis Can Date: 2000
Authors: Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11-02 Impact factor: 4.254
Authors: John D Norris; Ching-Yi Chang; Bryan M Wittmann; Rebecca S Kunder; Huaxia Cui; Daju Fan; James D Joseph; Donald P McDonnell Journal: Mol Cell Date: 2009-11-13 Impact factor: 17.970
Authors: Malcolm G Dunlop; Albert Tenesa; Susan M Farrington; Stephane Ballereau; David H Brewster; Thibaud Koessler; Paul Pharoah; Clemens Schafmayer; Jochen Hampe; Henry Völzke; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Susanna von Holst; Simone Picelli; Annika Lindblom; Mark A Jenkins; John L Hopper; Graham Casey; David Duggan; Polly A Newcomb; Anna Abulí; Xavier Bessa; Clara Ruiz-Ponte; Sergi Castellví-Bel; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri Aaltonen; Brent Zanke; Tom Hudson; Steven Gallinger; Ella Barclay; Lynn Martin; Maggie Gorman; Luis Carvajal-Carmona; Axel Walther; David Kerr; Steven Lubbe; Peter Broderick; Ian Chandler; Alan Pittman; Steven Penegar; Harry Campbell; Ian Tomlinson; Richard S Houlston Journal: Gut Date: 2012-04-05 Impact factor: 23.059
Authors: Brent W Zanke; Celia M T Greenwood; Jagadish Rangrej; Rafal Kustra; Albert Tenesa; Susan M Farrington; James Prendergast; Sylviane Olschwang; Theodore Chiang; Edgar Crowdy; Vincent Ferretti; Philippe Laflamme; Saravanan Sundararajan; Stéphanie Roumy; Jean-François Olivier; Frédérick Robidoux; Robert Sladek; Alexandre Montpetit; Peter Campbell; Stephane Bezieau; Anne Marie O'Shea; George Zogopoulos; Michelle Cotterchio; Polly Newcomb; John McLaughlin; Ban Younghusband; Roger Green; Jane Green; Mary E M Porteous; Harry Campbell; Helene Blanche; Mourad Sahbatou; Emmanuel Tubacher; Catherine Bonaiti-Pellié; Bruno Buecher; Elio Riboli; Sebastien Kury; Stephen J Chanock; John Potter; Gilles Thomas; Steven Gallinger; Thomas J Hudson; Malcolm G Dunlop Journal: Nat Genet Date: 2007-07-08 Impact factor: 38.330
Authors: C Jung; R-S Kim; H Zhang; S-J Lee; H Sheng; P J Loehrer; T A Gardner; M-H Jeng; C Kao Journal: Br J Cancer Date: 2005-06-20 Impact factor: 7.640
Authors: Jennifer L Beebe-Dimmer; Matthew Hathcock; Cecilia Yee; Linda A Okoth; Charles M Ewing; William B Isaacs; Kathleen A Cooney; Stephen N Thibodeau Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-24 Impact factor: 4.254
Authors: Thomas J Hoffmann; Lori C Sakoda; Ling Shen; Eric Jorgenson; Laurel A Habel; Jinghua Liu; Mark N Kvale; Maryam M Asgari; Yambazi Banda; Douglas Corley; Lawrence H Kushi; Charles P Quesenberry; Catherine Schaefer; Stephen K Van Den Eeden; Neil Risch; John S Witte Journal: PLoS Genet Date: 2015-01-28 Impact factor: 5.917
Authors: Cristina Villares Zabalza; Meike Adam; Christoph Burdelski; Waldemar Wilczak; Corina Wittmer; Stefan Kraft; Till Krech; Stefan Steurer; Christina Koop; Claudia Hube-Magg; Markus Graefen; Hans Heinzer; Sarah Minner; Ronald Simon; Guido Sauter; Thorsten Schlomm; Maria Christina Tsourlakis Journal: Oncotarget Date: 2015-05-20
Authors: Sofia Maia; Marta Cardoso; Pedro Pinto; Manuela Pinheiro; Catarina Santos; Ana Peixoto; Maria José Bento; Jorge Oliveira; Rui Henrique; Carmen Jerónimo; Manuel R Teixeira Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240